Leaflet LEVETIRACETAM PHARMASWISS 500mg film-coated tablets
Indicated for: epilepsy
Route of administration: oral
Substance: levetiracetam (antiepileptic)
ATC: N03AX14 (Nervous system | Antiepileptics | Other antiepileptics)
This medicine may affect your ability to drive or use machines.
Dose adjustment may be needed in liver disease.
Dose adjustment may be needed in kidney disease.
This medicine may cause dizziness or vertigo.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Seek medical help if suicidal thoughts or major behavior changes occur.
This medicine may cause drowsiness or reduced alertness.
Levetiracetam is an antiepileptic medication used to treat various types of seizures, including focal seizures, generalized tonic-clonic seizures, and myoclonic seizures. It is often prescribed as an adjunctive treatment but can also be used as monotherapy in certain cases.
This medication works by modulating neuronal activity, reducing the excessive excitability in the brain that leads to seizures. It is well-tolerated by most patients, with side effects typically being mild, such as drowsiness, dizziness, fatigue, or irritability. In rare cases, mood or behavioral changes, such as anxiety or depression, may occur.
Levetiracetam should be taken as prescribed by a doctor, and the dosage may be adjusted based on the patient's response. It is important not to stop the treatment abruptly, as this may increase the risk of seizures.
General data about LEVETIRACETAM PHARMASWISS 500mg
- Substance: levetiracetam
- Date of last drug list: 01-07-2015
- Commercial code: W57385003
- Concentration: 500mg
- Pharmaceutical form: film-coated tablets
- Quantity: 30
- Product type: generic
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Pharmaceutical forms available for levetiracetam
Concentrations available for levetiracetam
- 1000mg
- 100mg/ml
- 10mg/ml
- 15mg/ml
- 250mg
- 500mg
- 5mg/ml
- 750mg